What are the recommended antibiotics for acute bacterial sinusitis according to Queensland guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Queensland Guidelines for Antibiotics in Acute Bacterial Sinusitis

According to the most recent guidelines, high-dose amoxicillin-clavulanate (875/125 mg twice daily for adults) is the recommended first-line antibiotic treatment for acute bacterial sinusitis in Queensland. 1

First-Line Treatment Options

Adults:

  • First choice: Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 1
  • High-dose option: 2000 mg amoxicillin component twice daily for 5-7 days (for severe cases or high-risk patients) 1

Children:

  • First choice: Amoxicillin 45 mg/kg/day in 2 divided doses 2
  • High-dose option: Amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day of clavulanate) in 2 divided doses for:
    • Children younger than 2 years
    • Those attending childcare
    • Recent antibiotic use (within 4 weeks)
    • Moderate to severe illness 2

Alternative Options for Penicillin-Allergic Patients

For patients with penicillin allergy, the following alternatives are recommended:

  • Cefdinir 300 mg twice daily
  • Cefpodoxime 200 mg twice daily
  • Cefuroxime axetil 500 mg twice daily 1

Pathogens and Resistance Considerations

The main bacterial pathogens in acute bacterial sinusitis are:

  • Streptococcus pneumoniae
  • Haemophilus influenzae
  • Moraxella catarrhalis 2, 1

Antimicrobial resistance patterns vary by region, with:

  • 10-15% of S. pneumoniae isolates showing nonsusceptibility to penicillin nationally (up to 50-60% in some areas)
  • 10-42% of H. influenzae and nearly 100% of M. catarrhalis producing β-lactamase 2

Treatment Duration

The recommended duration of treatment is 5-7 days 1. This shorter course is supported by evidence showing comparable efficacy to traditional 10-14 day regimens while potentially reducing antibiotic resistance and side effects.

Treatment Failure Protocol

If no improvement is observed after 72 hours of treatment:

  1. Reassess the diagnosis
  2. Consider switching to an alternative antibiotic
  3. Consider referral to a specialist if symptoms are worsening 1

Special Considerations

  • Risk factors for resistant organisms: Recent antibiotic use (within 30 days), age younger than 2 years, and childcare attendance 2
  • Severe cases: For patients unable to tolerate oral medication or with severe symptoms, a single 50 mg/kg dose of ceftriaxone (IV or IM) can be used initially 2
  • Post-treatment follow-up: Patients should be reassessed within 3-5 days of starting treatment to evaluate effectiveness 1

Common Pitfalls to Avoid

  1. Overdiagnosis: Distinguishing viral from bacterial sinusitis is crucial. Bacterial sinusitis should be suspected with:

    • Persistent symptoms >10 days without improvement
    • Severe symptoms with high fever and purulent discharge for 3-4 consecutive days
    • Worsening symptoms after initial improvement
  2. Inappropriate antibiotic selection: Using macrolides (clarithromycin, azithromycin) as first-line therapy is not recommended due to high rates of resistance among S. pneumoniae.

  3. Inadequate dosing: Standard-dose amoxicillin may be insufficient in areas with high prevalence of resistant S. pneumoniae.

  4. Premature treatment changes: Allow 72 hours for clinical response before considering a change in therapy.

References

Guideline

Antibiotic Treatment Guidelines for Ear, Sinus, and Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.